Search results for "Diabetic Retinopathy"

showing 10 items of 134 documents

Beneficial effects of saffron (

2020

Saffron (Crocus sativus L.) has been traditionally used in food preparation and as a medicinal plant. It currently has numerous therapeutic properties attributed to it, such as protection against ischemia, as well as anticonvulsant, antidepressant, anxiolytic, hypolipidemic, anti-atherogenic, anti-hypertensive, antidiabetic, and anti-cancer properties. In addition, saffron has remarkable beneficial properties, such as anti-apoptotic, anti-inflammatory and antioxidant activities, due to its main metabolites, among which crocin and crocetin stand out. Furthermore, increasing evidence underwrites the possible neuroprotective role of the main bioactive saffron constituents in neurodegenerative …

crocindiabetic retinopathyglaucomaretinitis pigmentosaocular diseasescrocetinsaffronneuroprotectionReviewAMDsafranalCrocus sativus L.eye diseasesNeural regeneration research
researchProduct

Balance Sheet of Screening for Diabetic Retinopathy With a Mobile Non-Mydriatic Digital Camera in Burgundy, France

2009

Purpose: To assess the economic balance-sheet of screening for diabetic retinopathy (DR) with a mobile non-mydriatic digital camera in Burgundy, France, in a public health and economic perspective.Methods: The 72 lowest medicalised areas of Burgundy were visited. Retinal images were obtained with a non-mydriatic camera. To construct an economic model, we used available data on the prevalence of diabetes in Burgundy, the efficiency of the screening, the number of screened DR, blindness probability according to DR grading, the efficiency of laser therapy, the diabetic characteristics (gender, age, income, professional status and life expectancy) and medical costs induced by our campaign.Resul…

diabetic retinopathy[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansHealth care deliverymanpowerdetectionepidemiologic studieseconomicsclinical (human)
researchProduct

Retidiab®: Assessment of a continuing medical education website for the improvement of diabetic retinopathy management

2009

International audience; Aim: The aim of this study was to evaluate the ability of a continuing medical education (CME) website to improve the knowledge of ophthalmologists for the management of diabetic retinopathy (DR). Methods: A World Wide Web site called RETIDIAB® was created. At their first connexion, users had to answer a first test in order to evaluate their baseline level. Then they could have free access to the entire website, any time they wanted, with no obligation of duration. The website was composed of a course and different kind of trainings which were multiple choice questionnaires (MCQ) focused on the course, interpretation of diabetics’ fundus photographs, and case reports…

diabetic retinopathy[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

AUTOMATIC RETINA EXUDATES SEGMENTATION WITHOUT A MANUALLY LABELLED TRAINING SET

2011

International audience; Diabetic macular edema (DME) is a common vision threatening complication of diabetic retinopathy. In a large scale screening environment DME can be assessed by detecting exudates (a type of bright lesions) in fundus images. In this work, two new methods for the detection of exudates are presented. The methods do not require a lesion training set so the need to ground-truth data is avoided with significant time savings and independence from human error. We evaluate our algorithm with a new publicly available dataset from various ethnic groups and levels of DME. Also, we compare our results with two recent exudate segmentation algorithms on the same dataset. In all of …

genetic structures02 engineering and technologyFundus (eye)030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicine[ INFO.INFO-TI ] Computer Science [cs]/Image Processing0202 electrical engineering electronic engineering information engineeringmedicineMedical imagingSegmentationComputer visionRetinabusiness.industrySupervised learningDiabetic retinopathyImage segmentationmedicine.diseaseeye diseasesmedicine.anatomical_structure[INFO.INFO-TI] Computer Science [cs]/Image Processing [eess.IV]Computer-aided diagnosis[INFO.INFO-TI]Computer Science [cs]/Image Processing [eess.IV]020201 artificial intelligence & image processingArtificial intelligencebusiness
researchProduct

Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy

2014

In patients with diabetes mellitus (DM), early retinal microvascular alterations can be observed even before the clinical diagnosis of diabetic retinopathy. This study aimed to investigate morphological and functional changes in retinal microvascular blood flow in type 1 diabetic patients with and without peripheral neuropathy (PNP) as compared to nondiabetic controls. Retinal microvascular blood flow (RBF) was assessed using scanning laser Doppler flowmetry (Heidelberg Retina Flowmeter, Heidelberg Engineering, Germany) before and after stimulation with flicker light. PNP was assessed using the neuropathy disability score (NDS) and by the evaluation of the vibration perception threshold (V…

inorganic chemicalsmedicine.medical_specialtyEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineering-chemistry.chemical_compoundVibration perceptionMedizinische FakultätDiabetes mellitusOphthalmologyInternal Medicinemedicineheterocyclic compoundsddc:610RetinaType 1 diabetesbusiness.industryRetinalBlood flowDiabetic retinopathyOriginal Articlesmedicine.diseaseSurgeryenzymes and coenzymes (carbohydrates)Peripheral neuropathymedicine.anatomical_structurechemistrybusiness
researchProduct

Clinical and Molecular-Genetic Insights into the Role of Oxidative Stress in Diabetic Retinopathy: Antioxidant Strategies and Future Avenues

2020

Reactive oxygen species (ROS) overproduction and ROS-signaling pathways activation attack the eyes. We evaluated the oxidative stress (OS) and the effects of a daily, core nutritional supplement regimen containing antioxidants and omega 3 fatty acids (A/ω3) in type 2 diabetics (T2DM). A case-control study was carried out in 480 participants [287 T2DM patients with (+)/without (−) diabetic retinopathy (DR) and 193 healthy controls (CG)], randomly assigned to a daily pill of A/ω3. Periodic evaluation through 38 months allowed to outline patient characteristics, DR features, and classic/OS blood parameters. Statistics were performed by the SPSS 24.0 program. Diabetics displayed significantly h…

medicine.medical_specialtyAntioxidanttype 2 diabetes mellitusPhysiologyThiobarbituric acidmedicine.medical_treatmentClinical BiochemistryDietética y nutrición030209 endocrinology & metabolismmedicine.disease_causeBiochemistryArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineprevention of blindnessInternal medicineretinopathymedicineTBARSoxidative stressMolecular Biologyomega-3 fatty acidsVitamin Cbusiness.industrylcsh:RM1-950Cell BiologyDiabetic retinopathymedicine.diseaseMalondialdehydeAnatomía ocularlcsh:Therapeutics. PharmacologyantioxidantsEndocrinologychemistrycandidate biomarkers030221 ophthalmology & optometryOftalmologíabusinessOxidative stressRetinopathy
researchProduct

Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients.

2015

Purpose. Evaluate optimized fundus autofluorescence (FAF) imaging in early stages of diabetic retinopathy (DR) and relate findings with conventional colour fundus imaging and visual function in diabetic patients and control subjects.Materials and Methods. FAF and colour images were obtained using the CR-2 Plus digital nonmydriatic retinal camera in seven diabetic patients and thirteen control subjects. Visual-Functioning Questionnaire-25 (VFQ-25) and Diabetes Self-Management Questionnaire (DSMQ) were used to assess the quality of life and diabetes self-care. Contrast sensitivity function (CSF) was evaluated with the Vistech 6500 chart.Results. FAF and optimized-FAF imaging showed more retin…

medicine.medical_specialtyArticle Subjectgenetic structuresmedia_common.quotation_subjectFundus (eye)03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:OphthalmologyOphthalmologyDiabetes mellitusmedicineContrast (vision)030212 general & internal medicinemedia_commonRetinal pigment epitheliumbusiness.industryRetinalDiabetic retinopathymedicine.diseaseFundus autofluorescenceOphthalmologymedicine.anatomical_structurechemistrylcsh:RE1-994Visual function030221 ophthalmology & optometryOptometrybusinessResearch ArticleJournal of ophthalmology
researchProduct

Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a s…

2020

Purpose: to conduct a systematic review with network meta‐analysis (NMA) of randomized clinical trials (RCTs) comparing panretinal photocoagulation (PRP) versus anti‐vascular endothelial growth factor (VEGF) treatment alone or in combination with PRP, for proliferative diabetic retinopathy (PDR).Methods: PubMed, Medline and Embase databases were searched for RCTs comparing PRP versus intravitreal anti‐VEGF therapy and/or combined PRP and intravitreal anti‐VEGF for PDR. The primary outcome measures were the mean best corrected visual acuity (BCVA) change and the regression of neovascularization. Mean change of central macular thickness (CMT), the subgroup analyses of patients without diabeti…

medicine.medical_specialtyBevacizumabgenetic structurespegaptanibmedicine.medical_treatmentPegaptanibNetwork Meta-AnalysisVisual AcuityVitrectomyAngiogenesis Inhibitorsbevacizumablaw.inventionNeovascularization03 medical and health sciences0302 clinical medicineRandomized controlled trialaflibercept; bevacizumab; intravitreal anti-VEGF; panretinal photocoagulation; pegaptanib; proliferative diabetic retinopathy; ranibizumabintravitreal anti-VEGFlawOphthalmologyVitrectomymedicineHumansranibizumabAfliberceptDiabetic RetinopathyLaser Coagulationbusiness.industryafliberceptGeneral MedicineDiabetic retinopathymedicine.diseasepanretinal photocoagulationeye diseasesOphthalmologyIntravitreal Injections030221 ophthalmology & optometrysense organsRanibizumabmedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugproliferative diabetic retinopathy
researchProduct

Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration

2018

Abstract Fibrates are drugs that reduce triglycerides, elevate high-density lipoproteins, as well as decrease small, dense LDL particles. The results of a study have recently been published by the Cochrane Collaboration on fibrates efficacy and safety in the primary prevention of cardiovascular disease. This study includes a systematic review and a meta-analysis of 6 studies (16,135 patients) that evaluated the clinical benefits of fibrates compared to placebo use or other lipid-lowering drugs. This review showed evidence of a protective effect of the fibrates compared with placebo as regards a reduction 16% of a compound objective of death due to cardiovascular disease, non-fatal myocardia…

medicine.medical_specialtyDiseasePlacebochemistry.chemical_compoundInternal medicinePrimary preventionmedicineHumansMyocardial infarctionHypolipidemic AgentsGeneral Environmental ScienceCreatinineCochrane collaborationbusiness.industryFibric AcidsGeneral EngineeringDiabetic retinopathymedicine.diseaseLipidsPrimary PreventionTotal mortalitychemistryCardiovascular DiseasesCreatinineGeneral Earth and Planetary SciencesDrug Therapy CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessClínica e Investigación en Arteriosclerosis (English Edition)
researchProduct

Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience

2021

AbstractWe conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean change of best corrected visual acuity (BCVA) at 24 months. Secondary outcomes were 36-month mean BCVA, mean central macular thickness (CMT) change, rates of eyes receiving supplementary intravitreal therapy, cataract surgery, intraocular pressure (IOP)-lowering drops and glaucoma surgery. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Nine real-world studies were included.…

medicine.medical_specialtyIntraocular pressuregenetic structuresSciencemedicine.medical_treatmentAnti-Inflammatory AgentsArticleMacular Edema03 medical and health sciences0302 clinical medicineDiabetes complicationsFluocinolone acetonideOphthalmologymedicineGlaucoma surgeryHumans030212 general & internal medicineGlucocorticoidsIntraocular PressureDrug ImplantsDiabetic RetinopathyMultidisciplinarybusiness.industryQRCataract surgeryRetinal diseaseseye diseasesConfidence intervalFluocinolone AcetonideDiabetic macular oedemaMeta-analysis030221 ophthalmology & optometryMedicinesense organsImplantbusinessmedicine.drugScientific Reports
researchProduct